150,000+ articles · 127 conditions · peer-reviewed

Your Hormones. Decoded.

FemWiseIQ is the AI research companion built for women the medical system has dismissed. Ask anything.

Built for Women Whose Complexity Doesn't Fit A 15-Minute Appointment.

Connects your tracked patterns to 150,000+ peer-reviewed studies. Your data. Your science. Your answers.

Card required · Cancel anytime · First 250 get Founding Member pricing

150,000+
Peer-reviewed studies
127
Conditions Tracked & Cross-Referenced
0
AI hallucinations
Free
14-Day Trial · No Charge

Built for the woman whose symptoms don't fit the app.

Every answer draws on 12+ clinical-grade databases — including Cochrane, FDA DailyMed, PubMed, WHO IRIS, and more — with GRADE-level evidence scoring so you see how strong the science is.

Built for Women Whose Complexity Doesn't Fit A 15-Minute Appointment. Perimenopause, ADHD, PCOS, POTS & Autoimmune.

FemWiseIQ is a hormonal health companion and research navigator for women at every life stage — with a deep specialty in perimenopause and the complex conditions that travel with it.

Women in Perimenopause & Menopause
Navigating the hormone shift medicine still underserves. Explanations your doctor hasn't had time to give you.
Women with ADHD
Estrogen directly regulates dopamine. When it drops, your ADHD amplifies. FemWise connects these dots with research.
Women with Autoimmune Conditions
Hashimoto's, lupus, RA — autoimmune conditions interact with hormonal changes in ways most providers don't track.
Women with PCOS
Insulin, androgens, estrogen — the interplay is complex. FemWise synthesizes the research around your specific picture.
Women with POTS & Dysautonomia
Hormonal fluctuations directly impact autonomic function. At any age — our youngest users are 19.
Neurodivergent Women
ADHD, autism, and hormonal complexity are deeply linked. FemWise is built for the intersection, not the average.
FemWiseIQ tracks 127 conditions across every life stage — from puberty and PCOS through perimenopause and post-menopause — because most women aren't dealing with one thing in isolation. They're dealing with five, across years.

Women Have Been Left Out Of The Research.
We're Putting Them Back In The Picture.

The data is stark — because women's research is historically underfunded, and the existing research is not accessible, personal, or actionable. Until now.

~40%

Of women felt they were misdiagnosed when seeking care for perimenopause symptoms — most treated for anxiety, depression, or panic attacks instead. Among those prescribed mental health medication, 39% believed they hadn't received the right diagnosis at all.

Biote National Survey, 2025 · 1,000+ U.S. women ages 30–60

The Research Gap
<30%
Of clinical trial participants are women — despite being 51% of the population
Nature, 2025 · FDA Analysis
6.8%
Of OB-GYN residents felt prepared to manage perimenopause
The Menopause Society Survey, 2024
58%
Of medical textbooks had no reference to menopause at all. 12% less than one paragraph.
UCL / ScienceDirect Review, 2023
Key Finding
1%
Of biopharma R&D spending targets non-cancer female conditions including menopause
Industry Data, 2025
What Women Actually Experience
85%
Did not feel adequately informed about perimenopause when symptoms began
Biote National Survey, 2025
26%
Learned about perimenopause from their doctor — while 42% turned to Google first
Biote National Survey, 2025
1 in 3
Women ages 45–54 report being misdiagnosed while seeking menopause support
Biote National Survey, 2025

Additional findings: 20% of women wait 12+ months for diagnosis · 18% feel concerns aren't fully addressed · 5% saw 11+ doctors before receiving support. Biote, 2025 · Kindra/Harris Poll

The Full Picture — Provider Training & Patient Experience
Provider Preparedness
PCPs with formal menopause training
<20%
20%
OB-GYN residents felt equipped
6.8%
6.8%
OB-GYN programs with any menopause curriculum
31%
31%
Residents feeling “barely comfortable” with menopause
80%
80%
Patient Experience
Felt misdiagnosed seeking perimenopause care
~40%
40%
Did not feel informed at symptom onset
85%
85%
Turned to Google instead of their doctor
42%
42%
Never told by their doctor they were in perimenopause
25%
25%
Provider: The Menopause Society (2024) · Nature (2025) · UCL/ScienceDirect (2023) · AJMC (2025) · AARP/Menopause Society training data   |   Patient: Biote National Survey 2025 (1,000+ U.S. women) · Kindra/Harris Poll · Published menopause literature

Women deserve better.

FemWiseIQ exists to close this gap. The research exists — 150,000+ peer-reviewed studies. We surface it, synthesize it, and personalize it so you can understand your body, advocate for yourself, and walk into appointments knowing exactly what to ask.

Women deserve better — real answers, built on real science.

How FemWiseIQ works

You track. We decode. You get answers — with citations.

The mechanism behind the moat — your tracked patterns become the filter on 150,000+ studies.

STEP 01

You track.

Symptoms, meds, cycle phase, labs, conditions — logged in seconds. Scattered signal, all yours.

STEP 02

We decode.

150K+ peer-reviewed studies, filtered through your conditions, meds, and cycle phase. No generic results.

STEP 03

You get answers.

Plain-English explanations. GRADE-scored citations. Ready to bring to your provider.

The more you use it, the smarter it gets about YOU.

What you can do inside

Four tools. Built to do what no cycle app can.

Perimenopause Symptom Tracking, Condition-Aware AI & Hormone Research — All Personalized To You.

Every feature exists because peer-reviewed research exists to back it. Nothing cosmetic. Nothing filler.

01 · THE HERO USED 40× / MONTH AVG

Ask anything. Get cited research.

Type any question in plain English. FemWiseIQ searches 150,000+ studies, weighted for your tracked patterns, conditions, and cycle phase.

150K+

Studies searched

< 4s

Avg response

3-5

Citations each

Why am I so tired after ovulation?

Your progesterone spikes post-ovulation — it's sedating by design. This is your body, not a flaw.

Progesterone's effects on GABAergic transmission

JAMA · 2024 · GRADE: HIGH

Last 3 cycles

Mood ↓ 3 days before period · 3/3 cycles

02 · YOUR PATTERNS

Connections across cycles, meds, and mood.

Log symptoms in 30 seconds. FemWiseIQ spots the pattern, backed by research, before you do.

FemWiseIQ APR 2026

Summary for provider

Perimenopausal shift with co-occurring ADHD amplification

32 logs 4 citations

03 · DOCTOR VISIT PDF

Walk in with evidence on your side.

Research-backed visit summary. Print-ready. Your story, translated into clinical.

Vyvanse 40mg · cycle D22

⤴ efficacy shifts with late-luteal estrogen drop

04 · MEDS INTELLIGENCE

Track, remind, correlate.

Layered intelligence on top of your symptoms. See which meds work — and how your cycle changes them.

Also inside: Lab interpretation · Life stage hormone maps · Save & share research

Connect to care

When you see 11 doctors and still don't have answers,

care isn't a luxury — it's infrastructure.

5%

of women saw 11+ doctors before receiving support for perimenopause symptoms.

20%

wait 12+ months for a diagnosis. 18% feel their concerns aren't fully addressed.

Biote National Survey, 2025 · 1,000+ U.S. women ages 30–60

FemWiseIQ connects you to care that listens.

Hormone-aware telehealth

OB-GYNs, functional medicine specialists, and HRT-certified providers who understand perimenopause and multi-condition complexity.

Direct-to-consumer hormone testing

FSH, estradiol, thyroid panels — when your doctor won't order them. Know what to test, understand the results.

Mental health specialists

Therapists and psychiatric providers who understand hormonal mood shifts — not ones who'll just prescribe SSRIs for perimenopause.

Doctor visit PDFs & research save-and-share

Build a research file. Walk into appointments with citations in hand. Translate your story into their language.

The research, the care, and the evidence — on the same team. Yours.

Most apps only track. We explain, with citations.

Not just another period tracker. Not a chatbot. We're the research & intelligence layer that Flo and Clue never built — for women whose health is too complex to fit a cycle app.

Capability Google & web ChatGPT & AI Flo & cycle apps Symptom trackers (e.g. Bearable) FemWiseIQ
Peer-reviewed sources only Mixed / ad-driven Can hallucinate Limited depth Varies 150,000+ peer-reviewed studies
Explains why — not just what Contradictory articles Unverified Cycle focus Tracks, rarely explains mechanism Mechanism + citation
Hormone + chronic condition intelligence Generic No persistent medical context Period-first Condition-agnostic 127+ conditions, intersections
Evidence quality (GRADE-style scoring) No No No No Yes — see strength of evidence
Doctor-ready export DIY Not clinical Limited Reports / exports Research + timeline + labs
Privacy by design Ad model Training / retention Varies Varies No ads; subscription-only model
Typical paid tier (US, indicative) Flo Premium ~$11.49/mo Varies by app $9.99/mo or $59/yr — 150K+ articles, ConditionAware AI
Covers all life stages (puberty → post-menopause) ~Cycle focus, limited depth ✗No persistent health context ~Period-first, limited life stage depth ~Period-first, limited life stage depth ✓All life stages — puberty through post-menopause

Every Answer Is Sourced, Cited, and Clinically Graded

FemWiseIQ indexes 150,000+ peer-reviewed studies across 12+ clinical-grade research databases — continuously updated, evidence-scored, and filtered for women's health relevance. When Ask FemWise gives you an answer, you see exactly which journal, which authors, and which year — so you can bring it to your provider with confidence.

Highest Evidence Tier
Cochrane Library
Gold-standard systematic reviews. GRADE Tier 4 evidence — the strongest evidence available in clinical research.
FDA Official
DailyMed (FDA)
Official FDA drug labels, Black Box warnings, and contraindication data. Critical for medication-hormone interaction intelligence.
Clinical Gold Standard
NAMS Menopause Journal
The North American Menopause Society's primary journal — the clinical gold standard for perimenopause and menopause research.
NIH Primary
PubMed / PubMed Central
The NIH's primary medical literature index — the foundation of evidence-based research.
Global Health
WHO IRIS
World Health Organization's institutional repository — unique non-Western population data unavailable elsewhere.
Pharmacology
DrugBank
Molecular-level drug interaction and pharmacology data — the mechanism layer behind our medication intelligence.
Women's Health
BMC Women's Health
High-relevance open-access women's health journal — indexed for direct women's health population applicability.
Systematic Reviews
Epistemonikos
Aggregates systematic reviews from 30+ databases — complementing Cochrane with broader coverage.
NIH Reference
NIH NCBI Bookshelf
NIH authority source for research gap identification and policy documents.
Open Access
CORE Aggregator
30M+ open-access research papers across disciplines.
Europe PMC
Europe PMC
European literature index with unique regional research coverage.
Behavioral Health
OSF Preprints
Behavioral health, ADHD, and trauma preprints — early research on the neurodivergent-hormone connection.
GRADE Evidence Scoring: Every source is scored using the GRADE clinical evidence framework — adapted to flag where research has historically excluded women. You see how strong the science is, not just what it says. 🔴 Research Gap tags surface where women's health data is structurally missing — so you know when the evidence is limited by design, not by science.

FemWiseIQ is an educational tool that connects your tracked patterns to a library of 150,000+ peer-reviewed studies. It is not a diagnostic tool and does not replace clinical care. All research surfaced is attributed to its original source.

Built with a privacy promise — and the architecture to keep it.

Your hormone and symptom data is intimate. We treat it that way.

Foundation, not an afterthought

FemWiseIQ was built with a privacy promise from day one. Your diagnoses never travel with your name to our AI layer. Your data is protected by design, not policy. Your subscription is our only revenue model — your data has no commercial value to us beyond that.

What that means in practice

We don't run ads. We don't sell access. Your conditions aren't sent to third parties. Row-level security isolates your data at the database layer. This isn't something we added later — it's how we built it.

Angela, Founder of FemWiseIQ
“At 36, my health changed and I became my own medical research analyst. Most of my closest friends spent 3–10 years fighting for diagnosis and treatment. Earlier information could have saved them years of pain. I built the tool I wish we'd had — because the gap between feeling awful and getting real answers should not be this wide.”

20 years building secure data platforms. Now building for women. FemWiseIQ is the research companion I wished existed.

Angela · Founder, FemWiseIQ · Truckee, CA
20 Yrs Secure Data Built For Women Privacy First

The Answers You’ve Been Looking For.

“I’ve been told my symptoms were anxiety for three years. FemWise found four studies linking my exact pattern to perimenopause-onset ADHD. I finally had something real to bring to my doctor.”

Beta User
Beta User — Age 34 · Early Perimenopause + ADHD

“The hormone graph for perimenopause made me cry. I’ve been trying to explain why I feel so unpredictable and nobody believed me. That graph is my life.”

Beta User
Beta User — Age 37 · Perimenopause + Hashimoto’s

Start free. Get Pro when you're ready.

Free
$0

14-day trial, then free tier.

  • Core Ask FemWise queries, limited daily
  • Basic symptom logging
  • Research library access
Start free
231 spots left
Founding Member
$199 once

+ $3.99/month forever

First 250 members only. Lifetime $3.99/mo pricing.

  • Everything in Pro
  • Lifetime $3.99/mo pricing
  • Direct feedback channel
  • Early access to new features
  • “Founding” badge in-app
Claim your spot

231 of 250 spots remaining

Founding member has no trial — your $199 is your commitment, and $3.99/mo locked forever is your reward. If you cancel, you lose Pro access like any subscriber. The founding rate cannot be reclaimed once cancelled.

The close · 250 spots · locked forever

Be one of the first 250.

$199 once + $3.99/month forever.

231 out of 250 spots remaining

Claim your spot →

Women deserve better. We're putting research, tools, and real answers in your hands — so you can finally understand what's happening in your own body.

Get the weekly research brief

One email a week. Research that didn't make it into your doctor's appointment. Unsubscribe anytime.